{
    "nct_id": "NCT05934838",
    "official_title": "A Feasibility Trial of Tazemetostat Plus CAR T Cell Therapy in B-cell Lymphomas",
    "inclusion_criteria": "* Confirmed diagnosis of DLBCL, FL, or MCL\n* Eligible to receive standard of care CAR T cells\n* Have received at least 1 prior therapies\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Active viral infection with HIV or hepatitis type B or C\n* Active, uncontrolled systemic fungal, bacterial or viral infection\n* Active treatment for another cancer\n* Pregnant or breastfeeding\n* Unable to take oral medication\n* Certain significant past medical history, such recent stroke, pulmonary embolism, myocardial infarction, congestive heart failure, uncontrolled hypertension, or certain arrhythmias",
    "miscellaneous_criteria": ""
}